European Lung Cancer Therapeutics Markets

1. EXECUTIVE SUMMARY

Overview

• Overview of the European Lung Cancer Therapeutics Markets

2. GLOSSARY OF TERMS

List of Terms

• Abbreviations

3. RESEARCH METHODOLOGY

Research Objectives and Scope

• Methodology
• Assumptions and Limitations

4. MARKET OVERVIEW

Introduction

• Disease Characteristics
• Epidemiology

5. INDUSTRY CHALLENGES

Industry Challenges for the European Lung Cancer Therapeutics Market

• Challenges Faced by Pharmaceutical and Biotech Companies

6. TOTAL EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Overview and Definitions

• Introduction
• Market Drivers
• Market Restraints
• Current Therapeutic Options
• Future Therapeutic Approaches
• Market Engineering Measurement Analysis

Competitive Analysis

• Pipeline Analysis

7. TOTAL FORECASTS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Forecasts

• Patient Forecasts
• Market Revenue Forecasts
• Geographical Trends

8. PRICING AND REIMBURSEMENTS

Pricing and Reimbursements Issues

• Pricing and Reimbursements in Europe

9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Market Engineering Recommendations

• Strategic Recommendations

10. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

• Key Participants in the Lung Cancer Therapeutics Market

11. DECISION SUPPORT DATABASES

Habitual Indicators

• Prevalence of Smokers
• Prevalence of Male Smokers
• Prevalence of Female Smokers
• Per Capita Consumption of Cigarette
• Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market